Advanced Instruments Merged Under Nova Biomedical Name

This transformation is expected to deliver greater value to customers across the biopharmaceutical and clinical markets. Advanced Instruments has also unveiled a refreshed brand identity and logo across the merged organization, reflecting its forward-looking vision and deep commitment to innovation.

This strategic merger brings together two industry leaders with complementary strengths in analytical instrumentation, R&D, and global customer support. By combining their technologies and expertise, both companies are better positioned to support customer workflows, accelerate biopharmaceutical development, and improve patient care worldwide.

While the Advanced Instruments name will evolve into a product portfolio brand for its osmolality testing solutions, it will remain a symbol of excellence within the Nova Biomedical umbrella. Customers can now see the Nova Biomedical name and new visual identity reflected across the communications, digital assets, and products of Advanced Instruments. This branding update is designed to signal investment by Advanced Instruments in the future and its commitment to staying at the forefront of life science innovation.

Advanced Instruments has affirmed that this is only a branding change with legal entities, operational processes, and customer interactions remaining unchanged. The company’s customers can continue working with their existing sales and service contacts and process orders and inquiries as usual.

"Our shared values—innovation, customer focus, and dedication to quality—are the foundation of this merger," said Byron Selman, President & CEO of Nova Biomedical. "Operating under the Nova Biomedical name allows us to amplify our global presence and continue delivering gold-standard solutions to our customers."

Related Links:
Advanced Instruments
Nova Biomedical